Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Non Operating Income (2019 - 2025)

IDEAYA Biosciences' Non Operating Income history spans 7 years, with the latest figure at $11.3 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 18.29% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $45.6 million, down 13.11%, while the annual FY2025 figure was $45.6 million, 13.11% down from the prior year.
  • Non Operating Income for Q4 2025 was $11.3 million at IDEAYA Biosciences, up from $10.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $15.1 million in Q3 2024 and bottomed at $104000.0 in Q2 2021.
  • The 5-year median for Non Operating Income is $5.4 million (2023), against an average of $6.2 million.
  • The largest annual shift saw Non Operating Income crashed 73.79% in 2021 before it soared 1328.03% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $157000.0 in 2021, then skyrocketed by 1328.03% to $2.2 million in 2022, then skyrocketed by 255.13% to $8.0 million in 2023, then skyrocketed by 73.65% to $13.8 million in 2024, then dropped by 18.29% to $11.3 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Non Operating Income are $11.3 million (Q4 2025), $10.8 million (Q3 2025), and $11.3 million (Q2 2025).